Sarat Chandarlapaty Selected Research

Sarat Chandarlapaty Research Topics

Disease

77	Breast Neoplasms (Breast Cancer) 05/2024 - 08/2008
70	Neoplasms (Cancer) 05/2024 - 01/2008
10	Neoplasm Metastasis (Metastasis) 10/2022 - 07/2014
8	Disease Progression 05/2024 - 08/2011
6	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 05/2011
4	Brain Neoplasms (Brain Tumor) 10/2022 - 07/2014
3	Carcinogenesis 10/2023 - 01/2022
3	Heart Failure 10/2022 - 07/2014
2	Lobular Carcinoma 11/2023 - 01/2021
2	Ductal Carcinoma 01/2021 - 01/2018
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 05/2014
2	Diarrhea 01/2021 - 01/2020
2	Hyperglycemia 01/2021 - 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 11/2023
1	Neurofibrosarcoma (MPNST) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Hypokalemia 01/2021
1	Mucositis 01/2021
1	Exanthema (Rash) 01/2020

Drug/Important Bio-Agent (IBA)

32	Estrogen ReceptorsIBA 05/2024 - 12/2013
16	Hormones (Hormone)IBA 05/2024 - 12/2013
15	Phosphotransferases (Kinase)IBA 04/2024 - 01/2008
14	Trastuzumab (Herceptin)FDA Link 03/2022 - 08/2008
13	ErbB Receptors (EGF Receptor)IBA 10/2022 - 01/2008
11	human ERBB2 proteinIBA 05/2023 - 05/2010
9	LigandsIBA 05/2024 - 11/2012
9	Fulvestrant (Faslodex)FDA Link 11/2023 - 04/2015
8	Estrogens (Estrogen)FDA Link 10/2021 - 12/2013
7	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2014
7	Cell-Free Nucleic AcidsIBA 01/2022 - 10/2016
6	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 07/2017
5	Estrogen Receptor Modulators (Antiestrogen)IBA 05/2024 - 08/2017
5	capivasertibIBA 04/2024 - 07/2017
5	AlpelisibIBA 04/2024 - 04/2015
5	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 05/2011
5	Progesterone Receptors (Progesterone Receptor)IBA 10/2022 - 07/2014
4	Estrogen Receptor alphaIBA 05/2024 - 02/2016
4	Immunoconjugates (Immunoconjugate)IBA 05/2023 - 01/2021
4	Protein Isoforms (Isoforms)IBA 08/2022 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2008
3	Cadherins (E-Cadherin)IBA 11/2023 - 01/2018
3	Oncogene Proteins (Oncogene Protein)IBA 01/2023 - 06/2014
3	Aromatase InhibitorsIBA 09/2022 - 08/2017
3	pertuzumabIBA 03/2022 - 08/2017
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 05/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2008
3	Lapatinib (GW572016)FDA Link 10/2018 - 05/2010
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2016 - 01/2008
3	tanespimycin (17AAG)IBA 08/2011 - 01/2008
2	EnzymesIBA 05/2024 - 01/2021
2	Everolimus FDA Link 04/2024 - 03/2017
2	Cyclin-Dependent Kinase 4IBA 11/2023 - 12/2018
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2023 - 01/2019
2	ChromatinIBA 01/2023 - 01/2019
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2023 - 01/2018
2	Selective Estrogen Receptor Modulators (SERM)IBA 09/2022 - 11/2018
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022 - 10/2019
2	MethyltransferasesIBA 01/2022 - 01/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021 - 03/2014
2	Circulating Tumor DNAIBA 01/2020 - 11/2015
2	neratinibIBA 01/2020 - 10/2018
2	Cyclin EIBA 10/2019 - 03/2011
2	Tamoxifen FDA LinkGeneric 01/2019 - 11/2018
2	AndrogensIBA 01/2018 - 01/2016
2	STA 9090IBA 08/2017 - 06/2014
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016 - 06/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2014 - 04/2012
2	Tyrosine Kinase InhibitorsIBA 05/2010 - 01/2008
1	Cyclin DIBA 05/2024
1	Cyclin D1IBA 05/2024
1	APOBEC-1 DeaminaseIBA 05/2024
1	Peptides (Polypeptides)IBA 05/2024
1	Retinoblastoma ProteinIBA 11/2023
1	AntigensIBA 05/2023
1	sacituzumab govitecanIBA 05/2023
1	trastuzumab deruxtecanIBA 05/2023
1	Cytotoxins (Cytolysins)IBA 05/2023
1	Steroid Receptors (Steroid Receptor)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Verteporfin (Visudyne)FDA Link 01/2022
1	Polycomb Repressive Complex 2IBA 01/2022
1	Retroelements (Retrotransposon)IBA 01/2022
1	SteroidsIBA 10/2021
1	Androstenedione (4 Androstene 3,17 dione)IBA 10/2021
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 04/2021
1	16-fluoroestradiolIBA 01/2021
1	RNA Splice SitesIBA 01/2021
1	CateninsIBA 01/2021
1	elgemtumabIBA 01/2021
1	PyrimidinesIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	Lipase (Acid Lipase)FDA Link 01/2021
1	monomethyl auristatin EIBA 11/2020
1	ZirconiumIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020

Therapy/Procedure

59	Therapeutics 05/2024 - 08/2008
5	Drug Therapy (Chemotherapy) 01/2018 - 01/2008
2	Neoadjuvant Therapy 03/2022 - 10/2015
1	Immunotherapy 05/2023